Castlight Health (CSLT) Receiving Somewhat Favorable Media Coverage, Analysis Finds
Media coverage about Castlight Health (NYSE:CSLT) has been trending somewhat positive on Friday, Accern Sentiment Analysis reports. The research firm rates the sentiment of media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Castlight Health earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave news headlines about the software maker an impact score of 45.6488903203992 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
A number of equities analysts recently weighed in on CSLT shares. Zacks Investment Research lowered shares of Castlight Health from a “buy” rating to a “hold” rating in a research note on Monday, January 1st. Canaccord Genuity raised shares of Castlight Health from a “hold” rating to a “buy” rating in a research note on Tuesday, October 10th. Chardan Capital reduced their target price on shares of Castlight Health from $6.50 to $6.30 and set a “buy” rating for the company in a research note on Thursday, October 26th. BidaskClub lowered shares of Castlight Health from a “hold” rating to a “sell” rating in a research note on Wednesday, October 18th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $5.00 target price on shares of Castlight Health in a research note on Wednesday, October 25th. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the stock. Castlight Health presently has an average rating of “Hold” and a consensus price target of $5.22.
Shares of Castlight Health (NYSE:CSLT) traded down $0.05 during midday trading on Friday, reaching $4.00. 482,900 shares of the company were exchanged, compared to its average volume of 253,837. The firm has a market cap of $534.95, a price-to-earnings ratio of -8.51 and a beta of 1.66. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.94 and a current ratio of 1.94. Castlight Health has a 12-month low of $3.05 and a 12-month high of $4.75.
In other Castlight Health news, CEO John C. Doyle sold 13,686 shares of the business’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.71, for a total transaction of $50,775.06. Following the sale, the chief executive officer now directly owns 123,705 shares of the company’s stock, valued at approximately $458,945.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Mangini Siobhan Nolan sold 8,866 shares of the business’s stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $3.70, for a total transaction of $32,804.20. Following the sale, the chief financial officer now directly owns 78,561 shares in the company, valued at $290,675.70. The disclosure for this sale can be found here. Insiders have sold a total of 22,778 shares of company stock worth $84,411 over the last three months. Insiders own 24.38% of the company’s stock.
About Castlight Health
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.